mrna-4157, a novel mrna vaccine, with pembrolizumab in melanoma
Published 1 year ago • 659 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
2:14
keynote-942: dmfs findings of a personalized mrna vaccine in melanoma
-
4:10
a personalized mrna vaccine with pembrolizumab in melanoma
-
1:05
3-year update from the keynote-942 trial: mrna-4157 (v940) pembrolizumab in resected melanoma
-
1:39
unanswered questions in the use of mrna-based personalized cancer vaccines
-
4:40
new study finds mrna vaccine helps battle against melanoma
-
0:45
highlighting the advantages of neoantigen mrna vaccines in melanoma
-
0:59
can personalized mrna vaccines be applicable in lung cancer?
-
1:26
the future of personalized, neoantigen cancer vaccines
-
0:52
highlights in melanoma at aacr 2023
-
4:22
neoantigen vaccine with pembrolizumab has clear benefit in resected melanoma
-
2:53
dr. jeffrey weber discusses promising results of mrna-based melanoma vaccine trial
-
6:11
dr. meredith mckean on mrna combined immunotherapy for melanoma – nbclx
-
1:57
melanoma study finds mrna vaccine combined with standard treatment could reduce recurrence
-
1:00
more mrna vaccines for 2024
-
1:27
developing personalized therapeutic cancer vaccines for melanoma
-
1:22
interpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
-
0:50
melanoma mrna vaccine may improve life span of patients
-
6:29
science fiction becomes fact: neoantigen therapy in melanoma
-
3:09
advances in utilizing neoadjuvant immunotherapy in melanoma